Prognosis of recurrent non-small cell lung cancer following complete resection

Prognosis following recurrence subsequent to complete resection of non-small-cell lung cancer (NSCLC) is considered a multifactorial process dependent on clinicopathological, biological and treatment characteristics. Gefitinib was approved for lung cancer treatment in Japan in 2002. The aim of the c...

Descripción completa

Detalles Bibliográficos
Autores principales: SASAKI, HIDEFUMI, SUZUKI, AYUMI, TATEMATSU, TSUTOMU, SHITARA, MASAYUKI, HIKOSAKA, YU, OKUDA, KATSUHIRO, MORIYAMA, SATORU, YANO, MOTOKI, FUJII, YOSHITAKA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961426/
https://www.ncbi.nlm.nih.gov/pubmed/24944713
http://dx.doi.org/10.3892/ol.2014.1861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961426/
https://www.ncbi.nlm.nih.gov/pubmed/24944713
http://dx.doi.org/10.3892/ol.2014.1861

Ejemplares similares